NO912391D0 - Kaseinfraksjon for terapeutisk, profylaktisk og/eller diagnostisk anvendelse paa infeksjoner i aandedrettsorganene. - Google Patents

Kaseinfraksjon for terapeutisk, profylaktisk og/eller diagnostisk anvendelse paa infeksjoner i aandedrettsorganene.

Info

Publication number
NO912391D0
NO912391D0 NO912391A NO912391A NO912391D0 NO 912391 D0 NO912391 D0 NO 912391D0 NO 912391 A NO912391 A NO 912391A NO 912391 A NO912391 A NO 912391A NO 912391 D0 NO912391 D0 NO 912391D0
Authority
NO
Norway
Prior art keywords
infections
prophylactic
therapeutic
organizations
breathing
Prior art date
Application number
NO912391A
Other languages
English (en)
Norwegian (no)
Other versions
NO912391L (no
Inventor
Bengt Andersson
Gustaf Aniansson
Ragnar Lindstedt
Catharina Eden Svanborg
Original Assignee
Bengt Andersson
Gustaf Aniansson
Ragnar Lindstedt
Catharina Eden Svanborg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bengt Andersson, Gustaf Aniansson, Ragnar Lindstedt, Catharina Eden Svanborg filed Critical Bengt Andersson
Publication of NO912391D0 publication Critical patent/NO912391D0/no
Publication of NO912391L publication Critical patent/NO912391L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/202—Casein or caseinates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Polymers & Plastics (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Catching Or Destruction (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Respiratory Apparatuses And Protective Means (AREA)
NO91912391A 1989-10-30 1991-06-19 Kaseinfraksjon for terapeutisk, profylaktisk og/eller diagnostisk anvendelse paa infeksjoner i aandedrettsorganene. NO912391L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8903625A SE465109B (sv) 1989-10-30 1989-10-30 Antibakteriell komposition
PCT/SE1990/000702 WO1991006308A1 (en) 1989-10-30 1990-10-30 A casein fraction for therapeutic, profylactic and/or diagnostic use in infections of the respiratory tract

Publications (2)

Publication Number Publication Date
NO912391D0 true NO912391D0 (no) 1991-06-19
NO912391L NO912391L (no) 1991-06-19

Family

ID=20377332

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91912391A NO912391L (no) 1989-10-30 1991-06-19 Kaseinfraksjon for terapeutisk, profylaktisk og/eller diagnostisk anvendelse paa infeksjoner i aandedrettsorganene.

Country Status (15)

Country Link
EP (1) EP0454813B1 (sv)
JP (1) JPH04503077A (sv)
KR (1) KR920700678A (sv)
AT (1) ATE170754T1 (sv)
AU (1) AU633647B2 (sv)
CA (1) CA2044244A1 (sv)
DE (1) DE69032646T2 (sv)
DK (1) DK0454813T3 (sv)
ES (1) ES2121755T3 (sv)
FI (1) FI102516B (sv)
HU (1) HU212935B (sv)
NO (1) NO912391L (sv)
RU (1) RU2035913C1 (sv)
SE (1) SE465109B (sv)
WO (1) WO1991006308A1 (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538952A (en) * 1994-05-26 1996-07-23 Abbott Laboratories Inhibition of infection of mammalian cells by respiratory syncytial virus
US5506209A (en) * 1994-05-26 1996-04-09 Abbott Laboratories Product for inhibition of infection of mammalian cells by respiratory syncytial virus
US5707968A (en) * 1994-05-26 1998-01-13 Abbott Laboratories Inhibition of attachment of H.influenzae to human cells
EP0760674A1 (en) * 1994-05-26 1997-03-12 Abbott Laboratories Inhibition of infection of mammalian cells by respiratory syncytial virus
US5643880A (en) * 1994-05-26 1997-07-01 Abbott Laboratories Product for inhibition of attachment of H. influenzae to human cells
CA2190610A1 (en) * 1994-05-26 1995-12-07 Pradip Mukerji Inhibition of attachment of h. influenzae to human cells
US5942254A (en) * 1995-02-27 1999-08-24 Abbott Laboratories Phosphorylated recombinant human β-casein expressed in a bacterial system
WO1997026320A2 (en) * 1995-11-06 1997-07-24 Abbott Laboratories Product for inhibition of attachment of h. influenzae to human cells
NZ322369A (en) * 1995-11-06 1999-11-29 Abbott Lab Use of phosphorylated BETA H.influenzae
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
WO2004047778A1 (en) 2002-11-26 2004-06-10 Uc Tech Materials and methods for preventing and treating microbe-mediated epithelial disorders
BRPI0814412A2 (pt) 2007-07-06 2017-05-23 Laclede Inc uso de enzimas hidrolíticas e oxidativas para dissolver biofilme nas passagens das vias aéreas

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1496671A (en) * 1975-03-27 1977-12-30 Grindstedvaerket As Anti-cancer-active sour milk fraction
FR2491334A1 (fr) * 1980-10-03 1982-04-09 Inst Nat Sante Rech Med Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant
FR2592769B1 (fr) * 1986-01-10 1990-10-12 Agronomique Inst Nat Rech Procede d'obtention d'une matiere enrichie en caseine beta, appareillage pour la mise en oeuvre de ce procede, et application des produits obtenus par ce procede comme aliments, complements alimentaires ou additifs en industrie alimentaire et pharmaceutique ou dans la preparation de peptides a activite physiologique
JP2631470B2 (ja) * 1987-05-15 1997-07-16 雪印乳業株式会社 感染防御剤

Also Published As

Publication number Publication date
ES2121755T3 (es) 1998-12-16
ATE170754T1 (de) 1998-09-15
FI913154A0 (fi) 1991-06-28
SE8903625D0 (sv) 1989-10-30
KR920700678A (ko) 1992-08-10
DE69032646D1 (de) 1998-10-15
EP0454813A1 (en) 1991-11-06
EP0454813B1 (en) 1998-09-09
RU2035913C1 (ru) 1995-05-27
HU212935B (en) 1996-12-30
SE465109B (sv) 1991-07-29
FI102516B1 (sv) 1998-12-31
AU6647090A (en) 1991-05-31
SE8903625L (sv) 1991-05-01
DK0454813T3 (da) 1999-02-01
AU633647B2 (en) 1993-02-04
FI102516B (sv) 1998-12-31
DE69032646T2 (de) 1999-05-27
CA2044244A1 (en) 1991-05-01
JPH04503077A (ja) 1992-06-04
WO1991006308A1 (en) 1991-05-16
NO912391L (no) 1991-06-19

Similar Documents

Publication Publication Date Title
NO912391D0 (no) Kaseinfraksjon for terapeutisk, profylaktisk og/eller diagnostisk anvendelse paa infeksjoner i aandedrettsorganene.
EP2261358A3 (en) Novel streptococcus antigen
ATE165395T1 (de) Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen
BR0013814A (pt) Métodos de tratamentos de um paciente humano suscetìvel a ou diagnosticado com uma doença com anticorpos anti-erbb2, artigos industrializados, métodos de tratamentos de câncer em pacientes humanos e usos do anticorpo anti-erbb2
BR1101088A (pt) Proteìna g do vìrus sincicial respiratório não glicosilada isolada e substancialmente pura
DE3853854D1 (de) Vakzin gegen Neisseria meningitidis Gruppe-B, Gammaglobulin und Transferfaktor.
EP1757697A3 (en) Group B streptococcus antigens
DK0458079T3 (da) Ultralyd-kontrastmidler, fremgangsmåde til deres fremstilling og deres anvendelse som diagnostika og terapeutika
ES530046A0 (es) Procedimiento para la obtencion de acidos quinoloncarboxilicos
EP1731166A3 (en) Streptococcus pneumoniae proteins and vaccines
CA2050910A1 (en) Human intra-acrosomal sperm antigen for use in a contraceptive vaccine
DE3788184D1 (de) Zahnärztliche Röntgendiagnostikeinrichtung zur Herstellung von Übersichtsaufnahmen von im Schädel verlaufenden Schichten.
GB9524934D0 (en) Treatment and diagnosis of infections due to helicobacter pylori
CA2326148A1 (en) Method for providing glutamine
DK398683D0 (da) Fremgangsmade til fremstilling af antistoffer
ES2136206T3 (es) Composicion antibacteriana que contiene alfalactalbumina multimerica.
WO1992021697A3 (en) Diagnostic peptides derived from m.tuberculosis antigens
DE69002946D1 (de) Paracetamol enthaltende arzneizubereitung.
BR9916549A (pt) Composição farmacêutica, vacina, proteìna, e, método para a prevenção ou tratamento de leishmaniose em um humano ou animal
DE3560262D1 (en) Hexapeptide, process for its preparation and pharmaceutical compositions thereof
Okubo et al. Pseudoplaque formation by cytophilic immunoglobulins in the sera of lupus patients as measured using reverse haemolytic plaque assay.
NO20000694D0 (no) FremgangsmÕte for fremstilling av kontrastmidler som i utstrakt grad er fri for bivirkninger
EP1950302A3 (en) Streptococcus antigens
ERNST Preliminary Report on the Clinical Use of Tuberculin
Reznik et al. A modern status of tick borrelioses foci in the south of the Turkmen SSR.